31 related articles for article (PubMed ID: 8866666)
1. Large diversity in transport-mediated methotrexate resistance in human leukemia cell line CCRF-CEM established in a high concentration of leucovorin.
Asai S; Miyachi H; Kobayashi H; Takemura Y; Ando Y
Cancer Sci; 2003 Feb; 94(2):210-4. PubMed ID: 12708499
[TBL] [Abstract][Full Text] [Related]
2. Cellular pharmacokinetic of methotrexate and its modulation by folylpolyglutamate synthetase and γ-glutamyl hydrolase in tumor cells.
Tang F; Zou L; Chen J; Meng F
PLoS One; 2024; 19(6):e0302663. PubMed ID: 38833640
[TBL] [Abstract][Full Text] [Related]
3. Dynamic genomic changes in methotrexate-resistant human cancer cell lines beyond DHFR amplification suggest potential new targets for preventing drug resistance.
Meng XN; Ma JF; Liu YH; Li SQ; Wang X; Zhu J; Cai MD; Zhang HS; Song T; Xing S; Hou LQ; Guo H; Cui XB; Han J; Liu P; Ji GH; Sun WJ; Yu JC; Fu SB
Br J Cancer; 2024 May; 130(11):1819-1827. PubMed ID: 38594370
[TBL] [Abstract][Full Text] [Related]
4. Computational comparison of common event-based differential splicing tools: practical considerations for laboratory researchers.
Muller IB; Meijers S; Kampstra P; van Dijk S; van Elswijk M; Lin M; Wojtuszkiewicz AM; Jansen G; de Jonge R; Cloos J
BMC Bioinformatics; 2021 Jun; 22(1):347. PubMed ID: 34174808
[TBL] [Abstract][Full Text] [Related]
5. Glucocorticoid Resistant Pediatric Acute Lymphoblastic Leukemia Samples Display Altered Splicing Profile and Vulnerability to Spliceosome Modulation.
Sciarrillo R; Wojtuszkiewicz A; Kooi IE; Leon LG; Sonneveld E; Kuiper RP; Jansen G; Giovannetti E; Kaspers GJL; Cloos J
Cancers (Basel); 2020 Mar; 12(3):. PubMed ID: 32204435
[TBL] [Abstract][Full Text] [Related]
6. Molecular mechanisms of resistance to antifolates, a review.
Banerjee D; Ercikan-Abali E; Waltham M; Schnieders B; Hochhauser D; Li WW; Fan J; Gorlick R; Goker E; Bertino JR
Acta Biochim Pol; 1995; 42(4):457-64. PubMed ID: 8852336
[TBL] [Abstract][Full Text] [Related]
7. Mode of action of methotrexate-albumin in a human T-cell leukemia line and activity against an MTX-resistant clone.
Weigand M; Hartung G; Roboz J; Sieger S; Wolf M; Sinn H; Schrenk HH; Wiessler M; Frei E
Anticancer Drug Des; 2001; 16(4-5):227-37. PubMed ID: 12049481
[TBL] [Abstract][Full Text] [Related]
8. Folylpolyglutamate synthetase expression in antifolate-sensitive and -resistant human cell lines.
McGuire JJ; Russell CA
Oncol Res; 1998; 10(4):193-200. PubMed ID: 9778690
[TBL] [Abstract][Full Text] [Related]
9. [Primary study on establishment of namalwa 12/MTX resistant cell strain and its mechanism].
Chen J; Gu LJ; Ying DM; Shen M; Wu HJ
Ai Zheng; 2002 Dec; 21(12):1335-40. PubMed ID: 12520743
[TBL] [Abstract][Full Text] [Related]
10. Impaired polyglutamylation of methotrexate as a cause of resistance in CCRF-CEM cells after short-term, high-dose treatment with this drug.
Pizzorno G; Mini E; Coronnello M; McGuire JJ; Moroson BA; Cashmore AR; Dreyer RN; Lin JT; Mazzei T; Periti P
Cancer Res; 1988 Apr; 48(8):2149-55. PubMed ID: 2450647
[TBL] [Abstract][Full Text] [Related]
11. Impact of polyglutamation on sensitivity to raltitrexed and methotrexate in relation to drug-induced inhibition of de novo thymidylate and purine biosynthesis in CCRF-CEM cell lines.
Barnes MJ; Estlin EJ; Taylor GA; Aherne GW; Hardcastle A; McGuire JJ; Calvete JA; Lunec J; Pearson AD; Newell DR
Clin Cancer Res; 1999 Sep; 5(9):2548-58. PubMed ID: 10499632
[TBL] [Abstract][Full Text] [Related]
12. Evolution of drug resistance in CCRF-CEM human leukemia cells selected by intermittent methotrexate exposure.
McGuire JJ; Haile WH; Russell CA; Galvin JM; Shane B
Oncol Res; 1995; 7(10-11):535-43. PubMed ID: 8866666
[TBL] [Abstract][Full Text] [Related]
13. Resistance mechanisms to methotrexate in tumors.
Bertino JR; Göker E; Gorlick R; Li WW; Banerjee D
Stem Cells; 1996 Jan; 14(1):5-9. PubMed ID: 8820944
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
